TrialEuropean heart journal2020

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.

Pascal Vranckx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.